TATAA Biocenter was founded in 2001 as a center of excellence in qPCR services and gene expression analysis. It quickly became the world’s largest qPCR training provider, and later, Europe’s largest qPCR services provider.
TATAA was the first laboratory in Europe to obtain flexible ISO 17025 certification.
In recent years, TATAA researchers contributed to significant scientific achievements, such as pioneering subcellular protein profiling (2018), contributing to multicenter evaluations of microRNA extraction from blood samples and circulating cell-free DNA extraction (2019), developing GrandPerformance Sars-CoV-2 Detection kit (CE-IVD) (2020), unravelling false positive covid testing (2020) and contributing to the first single cell multi-omics profiling study (2020).Number of Partnerships: 10
